Find Eltoprazine manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

API Suppliers

API Suppliers

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 98224-03-4, 98206-09-8, 1-(2,3-dihydrobenzo[b][1,4]dioxin-5-yl)piperazine, 1-(2,3-dihydro-benzo[1,4]dioxin-5-yl)-piperazine, Eltoprazine [inn], 1-(1,4-benzodioxan-5-yl)piperazine
Molecular Formula
C12H16N2O2
Molecular Weight
220.27  g/mol
InChI Key
WVLHGCRWEHCIOT-UHFFFAOYSA-N
FDA UNII
510M006KO6

Eltoprazine
Eltoprazine has been used in trials studying the treatment of Schizophrenia and Cognitive Impairment.
1 2D Structure

Eltoprazine

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
1-(2,3-dihydro-1,4-benzodioxin-5-yl)piperazine
2.1.2 InChI
InChI=1S/C12H16N2O2/c1-2-10(14-6-4-13-5-7-14)12-11(3-1)15-8-9-16-12/h1-3,13H,4-9H2
2.1.3 InChI Key
WVLHGCRWEHCIOT-UHFFFAOYSA-N
2.1.4 Canonical SMILES
C1CN(CCN1)C2=C3C(=CC=C2)OCCO3
2.2 Other Identifiers
2.2.1 UNII
510M006KO6
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 1-(2,3-dihydro-1,4-benzodioxin-5-yl)piperazine

2. Du 28853

3. Du-28853

4. Eltoprazine Hydrochloride

5. Piperazine, 1-(2,3-dihydro-1,4-benzodioxin-5-yl)-, Hydrochloride

2.3.2 Depositor-Supplied Synonyms

1. 98224-03-4

2. 98206-09-8

3. 1-(2,3-dihydrobenzo[b][1,4]dioxin-5-yl)piperazine

4. 1-(2,3-dihydro-benzo[1,4]dioxin-5-yl)-piperazine

5. Eltoprazine [inn]

6. 1-(1,4-benzodioxan-5-yl)piperazine

7. 1-(2,3-dihydro-1,4-benzodioxin-5-yl)piperazine

8. Chembl282614

9. 510m006ko6

10. 1-(2,3-dihydrobenzo[1,4]dioxin-5-yl)piperazine

11. Eltoprazinum [latin]

12. Eltoprazina [spanish]

13. Ncgc00159533-01

14. Eltoprazina

15. Eltoprazinum

16. Eltoprazine [mi]

17. Eltoprazine [mart.]

18. Schembl177715

19. Piperazine, 1-(2,3-dihydro-1,4-benzodioxin-5-yl)-

20. Zinc1347

21. N-(benzodioxan-5-yl)piperazine

22. Dtxsid5048425

23. Unii-510m006ko6

24. Bcp19313

25. 1-(1,4-benzodioxan-5-yl)piperazin

26. Am1234

27. Bdbm50035057

28. Mfcd00868056

29. Pdsp1_000561

30. Pdsp2_000559

31. Akos016007669

32. 1-(1,4-benzodioxan-5-yl)-piperazine

33. Cs-3216

34. Db12883

35. Sb16767

36. Hy-16687

37. Ft-0667839

38. (2,3-dihydro[1,4]benzodioxin-5-yl)piperazine

39. H11026

40. 4-(2,3-dihydrobenzo[1,4]dioxin-5-yl)piperazine

41. A902315

42. L000982

43. 1-(2,3-dihydrobenzo[1,4]dioxin-5-yl)-piperazine

44. 4-(2,3-dihydrobenzo[1,4]dioxin-5-yl)-piperazine

45. Q5367896

46. 4-(2,3-dihydro-benzo[1,4]dioxin-5-yl)-piperazine

47. Brd-k86171477-003-01-9

48. (eltoprazine)1-(2,3-dihydro-benzo[1,4]dioxin-5-yl)-piperazine

49. 1-(2,3-dihydrobenzo[b][1,4]dioxin-5-yl)piperazine Hydrochloride Hydrochloride

2.4 Create Date
2005-08-08
3 Chemical and Physical Properties
Molecular Weight 220.27 g/mol
Molecular Formula C12H16N2O2
XLogP31.1
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count4
Rotatable Bond Count1
Exact Mass220.121177757 g/mol
Monoisotopic Mass220.121177757 g/mol
Topological Polar Surface Area33.7 Ų
Heavy Atom Count16
Formal Charge0
Complexity231
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Serotonin Receptor Agonists

Endogenous compounds and drugs that bind to and activate SEROTONIN RECEPTORS. Many serotonin receptor agonists are used as ANTIDEPRESSANTS; ANXIOLYTICS; and in the treatment of MIGRAINE DISORDERS. (See all compounds classified as Serotonin Receptor Agonists.)


ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty